Comparison of four different intra-articular injection sites in the knee: A cadaver study

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 15, Issue 5, 2007, Pages 573-577

  Esenyel, Cem ^a   Demirhan, Mehmet ^b   Esenyel, Meltem ^a   Sonmez, Mesut ^a   Kahraman, Sinan ^a   Senel, Berna ^b   Ozdes, Taskin ^b  

^a VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cadaver study; Hyaluronic acid; Intra articular injection; Knee; Osteoarthritis

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; HYALURONIC ACID; IMMUNOLOGICAL ADJUVANT; METHYLENE BLUE;

ADULT; AGED; ARTICLE; CADAVER; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; KNEE OSTEOARTHRITIS; MALE; METHODOLOGY; MIDDLE AGED;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; CADAVER; FEMALE; HUMANS; HYALURONIC ACID; INDICATORS AND REAGENTS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; METHYLENE BLUE; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

EID: 34247609962     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-006-0231-6     Document Type: Article

References (21)

1. Jackson DW, Simon TM, Aberman HM (2001) Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin Orthop 391(Suppl.):S14-S25
2. Balazs EA (1982) The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet AJ (eds) Disorders of the knee, 2nd edn. Lippincott, Philadelphia, pp 61-74
3. Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3-9
4. Smith MM, Ghosh P (1987) The synthesis of hyaluronic acid by human synovial flbroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 7:113-122
5. Altman RD, Moskowitz R (1998) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25:2203-2212
6. Pelletier JP, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in Viscosupplementation. J Rheumatol Suppl 39:19-24
7. Tobetto K, Yasui T, Ando T, Hayaishi M, Motohashi N, Shinogi M, Mori I (1992) Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 60:79-84
8. Forrester JV, Balazs EA (1980) Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40:435-446
9. Presti D, Scott JE (1994) Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH.) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 12:281-288
10. Ghosh P (1994) The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 12:75-82
11. Pozo MA, Balazs EA, Belmonte C (1997) Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 116:3-9
12. Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84-A(9):1522-1527
13. Adams ME (1993) An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis. J Rheumatol Suppl 39:16-18
14. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M (1995) The role of Visco-supplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multi-center trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal antiinflammatory drugs (NSAIDs) and NSA-IDs alone. Osteoarthr Cartil 3:213-225
15. Wobig M, Dickhut A, Maier R, Velter G (1998) Viscosupplementation with hyalan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20:410-423
16. Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritic knees with hyalan: a treatment schedule study. Curr Ther Res 55:220-232
17. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579-1585
18. Jones A, Regan M, Ledingham J, Pattrick M, Manhire A, Doherty M (1993) Importance of placement of intra-articular steroid injections. BMJ 307:1329-1330
19. Bliddal H (1999) Placement of intra-articular injections verified by mini-air arthrography. Ann Rheum Dis 58:641-643
20. Wind WM, Smolinski RJ (2004) Reliability of common knee injection sites with low-volume injections. J Arthroplasty 19(7):858-861
21. Waddell D, Estey D, Bricker DC, Marsala A (2001) Visco-supplementation under fluoroscopic control. Am J Med Sports 3:237-241